Trial Profile
Phase I trial of DSP 0565 for use in patients with treatment-resistant epilepsy.
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 21 Feb 2012
Price :
$35
*
At a glance
- Drugs DSP 0565 (Primary)
- Indications Epilepsy
- Focus Adverse reactions
- 21 Feb 2012 New trial record